Amgen(AMGN) - 2024 Q3 - Earnings Call Transcript

Amgen Inc. (NASDAQ:AMGN) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President Murdo Gordon - EVP, Global Commercial Operations Vikram Karnani - EVP & President, Global Commercial Operations & Medical Affairs (Rare Disease) James Bradner - EVP, Research and Development & Chief Scientific Officer Peter Griffith - EVP & CFO Conference Call Participants Salveen Richter - Goldman Sachs Olivia Brayer - Cantor Fitzgerald ...